Skip to main content
  • UQ Home
  • Contacts
  • Study
  • Maps
  • News
  • Events
  • Library
  • my.UQ
The University of Queensland

Dermatology Research CentreDermatology Research Centre

Site search
Homepage Site menu
  • Home
  • About
    • News
    • Events
  • Our People
  • Research
  • Contact
    • Staff Directory

Elucidating the Effects of Chimeric G-proteins in Cancer

Funding source:  Not Specific
Grant Type:  Not Specific

Conducted by Associate Professor Helmut Schaider (UQ DRC) in collaboration with Associate Professor Richard Sturm (UQ DRC), Professor H. Peter Soyer (UQ DRC), Professor Brian Gabrielli (UQ DI) and Professor Meenhard Herlyn (The Wistar Institute, Philadelphia, PA, US)

Aim of the study: G-protein coupled receptors (GPCRs) are amongst the most intensively studied cell membrane bound receptors heavily involved in cell signalling eliciting a broad spectrum of cellular responses. More than half of current drug targets are GPCRs. GPCRs signal through G-proteins. We recently found that a viral GPCR encoded by human cytomegalovirus, US28, is inducing cell death in melanoma cells through Galpha13 signalling. Based on this observation we are proposing that chimeric G-proteins mimicking US28 constitutive activity might be a new alternative strategy for the treatment of solid cancers.  

Methods: Cell culture, cloning, molecular biology, protein chemistry, functional assays, in vivo tumour models

Description: We have been generating a prototype of a fusion protein, which induces apoptosis and exerts anti-proliferative properties in many cell lines, including cancer cells. The fusion protein has so far been probed only in melanoma cell lines and more tailoring is necessary to increase the effectiveness. Specifically it is important to generate different constructs comprising mute sequences to test for enhanced induction of cell death. We will continue on engineering and characterizing fusion proteins and gain more insight into the nature of these fusion proteins. Cell type specific expression of fusion proteins, which might be also achieved with appropriate delivery systems, will be important for direct delivery of fusion-proteins.

Status:  Currently we are studying different engineered chimeric G-proteins for their overall effects on cell proliferation and phenotypic changes in vitro and in vivo. Based on successful screening some of the fusion proteins might be followed up for refinement and further analyses.

Researchers

Associate Professor Helmut Schaider
Associate Professor
Associate Professor Rick Sturm
Deputy Director
Professor H. Peter Soyer
Director

Associated Research

  • Naevi and Melanoma Studies

Related Projects

  • Australian Centre of Excellence in Melanoma Imaging and Diagnosis
  • A Genomics Approach for Screening of Patients at High Risk of Melanoma
  • 3D QMelanoma -Targeted early detection of melanoma utilising a 3D teledermatology (3DT) network
  • Immunohistochemistry and other Molecular Analysis of Phenotypically Charaterised Equivocal Melanocytic Proliferations Study
  • International Skin Imaging Collaboration (ISIC) Melanoma Project
© The University of Queensland
Enquiries: +61 7 3365 1111   |   Contact directory
ABN: 63 942 912 684   |   CRICOS Provider No: 00025B
Emergency
Phone: 3365 3333
Privacy & Terms of use   |   Feedback   |   Updated: 13 Jan 2016
Login